Cashu Markets
Cashu
Markets
TT

Tenax Therapeutics

TENX
NASDAQHealth Care

Recent Patents

tenx
over 1 year ago

Filed a patent for "use of a combination of levosimendan and an sglt-2 inhibitor to treat heart failure" on Wed, May 29, 2024

New US Patent
tenx
over 1 year ago

Filed a patent for "levosimendan for treating pulmonary hypertension heart failure with preserved ejection fraction (ph-hfpef)" on Thu, August 15, 2024

New US Patent
tenx
almost 2 years ago

Filed a patent for "levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)" on Thu, April 6, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

About Cashu MarketsContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...